drug · small molecule
abexinostat
Phase 3updated 3mo agoby Xynomic Pharmaceuticals Holdings Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 9 investigational indications.
targets
Histone deacetylase
all catalysts(0)
nothing on the calendar yet
Trials studying abexinostat
- phase1Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
- phase3A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- phase2Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
- phase2A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
- phase2A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients
- phase2Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
- phase1Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that